Elixxer Ltd.
ELIXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $633 | $11 | $54 | $55 |
| - Cash | $79 | $11 | $90 | $20 |
| + Debt | $13,953 | $13,159 | $12,557 | $11,914 |
| Enterprise Value | $14,507 | $13,159 | $12,521 | $11,949 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$204 | -$88 | -$46 | -$1,095 |
| % Margin | – | – | – | – |
| Net Income | -$773 | -$619 | -$545 | -$1,577 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.07 | -0.029 | -0.05 | -0.14 |
| % Growth | -139.7% | 41.6% | 64.3% | – |
| Operating Cash Flow | -$367 | $7 | -$81 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$367 | $7 | -$81 | $0 |